Navigation Links
Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study

s planned products; the ability of the company to consummate a favorable marketing agreement with a partner to market EpiCeram(TM); market acceptance of the company's planned products, the company's ability to successfully develop its licensed compounds, alone or in cooperation with others, into commercial products, the ability of the company to successfully prosecute and protect its intellectual property, and the company's ability to hire, manage and retain qualified personnel. The aforementioned factors do not represent an all inclusive list. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained in this press release. In particular, important factors that could cause actual results to differ materially from the company's forward-looking statements include general economic factors, business strategies, the state of capital markets, regulatory conditions, and other factors not currently known to the company, may be significant, now or in the future, and these factors may affect the company to a greater extent than indicated. All forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in this press release and in other documents that the company files from time to time with the Securities and Exchange Commission including its Annual Report on Form 10-KSB, Quarterly Reports on Form 10-QSB and Current Reports on Form 8-KSB to be filed in 2007. Except as required by law, the company does not undertake any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact

Ceragenix
Steven S. Porter, 720-946-6440
or
Liolios Group, Inc.
Investor Relations
Ron Both, 949-574-3860


'"/>




Page: 1 2 3

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
2. Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints
3. Ceragenix Announces New Publication of Scientific Research on Ceragenin Technology
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
(Date:12/22/2014)... Dec. 22, 2014   TRU-D SmartUVC LLC, ... disinfection robot, announced today that the General Services Administration ... November 2019.   This newly formed agreement ... levels of government purchasers, including Department of Veteran Affairs ... Homeland Security contacts purchasing solutions for the Ebola effort ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
(Date:12/24/2014)... For chic ladies, new fashionable outfits are ... of their Holiday Wish List, Angeldress.co.uk has chosen ... to accent ladies’ holiday wardrobe by launching a promotion on ... over the discount of 80% off, like a cheap suit. ... The company’s chic wedding dresses are among the hottest items ...
(Date:12/24/2014)... The 2014 Market Research Report ... in-depth research report on COC industry. For an ... including its definition, classification, application, industry chain structure, ... report also presents product specification, manufacturing process, and ... regions, technology and applications. Analysis also covers upstream ...
(Date:12/24/2014)... December 24, 2014 Verde Pointe Dental Associates ... ever. "Last years homemade Christmas sweater lit up, but ... The 2014 winner is Tandy Wilson for the second year ... enthusiast," says Kirk Kimmerling DDS. "She took pictures of the ... the sweater." , "Every year I enjoy stopping ...
(Date:12/24/2014)... 24, 2014 “ Relax Melodies ” ... AppWatch, which features the latest and coolest mobile applications ... a mobile technology expert and host of NewsWatch, conducted ... application soothes users so they can fall asleep. , ... adults say they have some sort of difficulty sleeping. ...
(Date:12/24/2014)... Aliso Viejo, California (PRWEB) December 24, 2014 ... the release of the ProDenoise from Pixel Film Studios. , ... film noise or grain in their footage,” said Christina Austin, ... to have in any Final Cut Pro X editors toolbox.” ... subdue film noise or grain in their footage with ProDenoise ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:Pixel Film Studios released the ProDenoise plugin for Final Cut Pro X today. 2
... Pa., Oct. 15 ViroPharma Incorporated,s (Nasdaq: VPHM ) ... released on Wednesday, October 28, 2009 before the open of ... conference call and live audio webcast at 9:00 a.m. Eastern ... ViroPharma management will discuss the 2009 third quarter and other ...
... ROCHESTER, Minn., Oct. 15 Mayo Clinic clinicians and ... and tested a tool to involve patients more in ... set of decision aid cards, could help patients make ... outcomes. The results of this randomized trial are in ...
... UV radiation, researchers say , THURSDAY, Oct. 15 ... are better than yellow at protecting skin against damaging ... scientists. , The researchers said their findings could lead ... The color of fabric is one of the most ...
... Passes Veterans Health Care Budget Reform and Transparency Act of ... Federation of Government Employees, today, lauded the efforts of Congress ... health care provided by the Department of Veterans Affairs. For ... in the VA funding process. AFGE applauds these members of ...
... , FAIRFAX, Va., Oct. 15 Four ... new, non-profit association, the Association of Gamete Donor Providers ... to share information and services, enhance educational programs and ... involved in all aspects of building families with the ...
... companies have been doing it for years. Why not ... thoughtful discussion in hospitals and as a way to ... secondary markets. One developer, North Carolina-based Oaks ... medical office buildings (MOBs). As such, the innovative developer ...
Cached Medicine News:Health News:ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009 2Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 2Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 3Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 4Health News:VA Funding Reform Bill Clears Congress 2Health News:Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 2
... Modes of Operation: , Standby: All toggle switches ... 60-ms bursts of 50 Hz separated by .75 s; ... pulse/s); single or repeat , Tetanus: 50 Hz ... Single (4 pulses/2 s); repeat (4 pulses/2 s; repeats ...
... of Operation: , Standby: All toggle switches at ... (1 pulse/s); 10 s (1 pulses/10 s) , ... (100 pulses/s) , Train-Of-Four: Single (4 pulses/2 s); ... , Output Current: Adjustable from 0-70 mA(HI range) ...
... of Operation: , Double Burst : 2 60-ms bursts ... 1 s (1 pulse/s) , Tetanus: 50 Hz ... Train-Of-Four: Single (4 pulses/2 s) , Output Current: Adjustable ... Monophasic pulses (200-us duration) , Indicators: Battery LED (green) ...
... standby switch maintains power to the instrument without ... pulse/s) , Tetanus: 100 Hz (200 pulses/s) ... Current: Adjustable from 0-70 mA , Stimulus ... Indicators: Battery LED (green) indicates that the units ...
Medicine Products: